Deverra Therapeutics, Inc. — Form C-AR (Regulation Crowdfunding)
Deverra Therapeutics, Inc. of Seattle, WA filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2025-04-10.
Offering
- Filed: 2025-04-10
- Form: C-AR
- Accession: 0001665160-25-000587
Issuer
- CIK: 0001822782
- Website: https://www.deverratx.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2020-09-11
- Address: 1600 Fairview Ave E STE 300, Seattle, WA, 98102
- Employees: 12
Financials (as filed)
- Total assets (most recent): $11.3M
- Cash (most recent): $115
- Revenue (most recent): $3.9M
- Revenue (prior): $1.7M
- Net income (most recent): $-3.7M
- Net income (prior): $1.7M
- Short-term debt: $1.7M
People (5)
| Name | Role | Location |
|---|
| Andrew Albert Kucharchuk | Interim CFO | South San Francisco, CA |
| Colleen Delaney | Scientific Founder and Chief Scientific Officer, EVP of RandD, Director | Wexford, PA |
| Colleen Delaney | Scientific Founder and Chief Scientific Officer, EVP of R&D, Director | Wexford, PA |
| Michael Yurkowsky | CEO | Seattle, WA |
| Michael Yurkowsky | CEO, Director and Chairman | Seattle, WA |
Reg CF filing history (7)
More